Patents by Inventor Zhulian JIANG

Zhulian JIANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT USE OF PYRROLOPYRIMIDINE COMPOUND, AND SOLID PHARMACEUTICAL COMPOSITION OF PYRROLOPYRIMIDINE COMPOUND
    Publication number: 20220072002
    Abstract: A treatment use of a pyrrolopyrimidine compound, and a solid pharmaceutical composition of a pyrrolopyrimidine compound. In particular, the present invention relates to a pyrrolopyrimidine compound or a pharmaceutical composition thereof for treating myeloproliferative neoplasms, and a method therefor or a use thereof.
    Type: Application
    Filed: December 24, 2019
    Publication date: March 10, 2022
    Applicant: CHIA TAI TIANQING PHARMACEUTICALGROUP CO., LTD.
    Inventors: Dong WANG, Qingxia LI, Jun DAI, Chen LI, Zhulian JIANG, Yanqing SUN, Jingjing CHEN, Lingling JIN, Jundong LIU, Qide LI
  • Azetidine derivative
    Patent number: 11014943
    Abstract: Disclosed in the present application are a compound represented by formula (I), or a pharmaceutically acceptable salt, a tautomer thereof, a stereoisomer thereof, or a geometrical isomer thereof, and uses thereof in the preparation of drugs for treating or preventing multiple myeloma.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: May 25, 2021
    Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP GO., LTD.
    Inventors: Jian Xiong, Cheng Xie, Kevin X Chen, Xiongbin Xu, Xuejin Zhang, Zhen Gong, Jian Li, Shuhui Chen, Aiming Zhang, Zhulian Jiang, Xiquan Zhang, Xin Tian
  • AZETIDINE DERIVATIVE
    Publication number: 20200115392
    Abstract: Disclosed in the present application are a compound represented by formula (I), or a pharmaceutically acceptable salt, a tautomer thereof, a stereoisomer thereof, or a geometrical isomer thereof, and uses thereof in the preparation of drugs for treating or preventing multiple myeloma.
    Type: Application
    Filed: February 28, 2018
    Publication date: April 16, 2020
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Jian XIONG, Cheng XIE, Kevin X CHEN, Xiongbin XU, Xuejin ZHANG, Zhen GONG, Jian LI, Shuhui CHEN, Aiming ZHANG, Zhulian JIANG, Xiquan ZHANG, Xin TIAN